amphetamine has been researched along with mdl 100907 in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 9 (33.33) | 29.6817 |
| 2010's | 13 (48.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bervoets, K; Maurel-Remy, S; Millan, MJ | 1 |
| Frank, RA; Kehne, JH; Moran, PM; Moser, PC | 1 |
| Brown, D; Byrd, G; Feldman, DJ; Flannery, R; Frank, RA; Kehne, JH; Shah, S; Soni, S | 1 |
| Carlsson, A; Carlsson, ML; Martin, P; Nilsson, M; Sorensen, SM; Waters, N; Waters, S | 1 |
| Heron-Maxwell, CL; O'Neill, MF; Shaw, G | 1 |
| Ichikawa, J; Kuroki, T; Meltzer, HY | 1 |
| Rimmerman, N; Weiner, I; Zuckerman, L | 1 |
| Gray, JA; Joseph, MH; McDonald, LM; Moran, PM; Stephenson, JD; Vythelingum, GN | 1 |
| Marona-Lewicka, D; Nichols, DE; Thisted, RA | 1 |
| Kruse, CG; McCreary, AC; Olijslagers, JE; Perlstein, B; Siarey, R; Wadman, WJ; Werkman, TR | 1 |
| Asgari, K; Bezzina, G; Body, S; Bradshaw, CM; Cheung, TH; Fone, KC; Glennon, JC; Szabadi, E | 1 |
| Ahmad, R; Egerton, A; Grasby, PM; Hirani, E | 1 |
| Greenshaw, AJ; Hayes, DJ; Mosher, TM | 1 |
| Hinchliffe, RM; Huszar, SL; Hutson, PH; Pachmerhiwala, R; Smith, SM; Uslaner, JM; Vardigan, JD | 1 |
| Markou, A; Semenova, S | 1 |
| Larrauri, JA; Levin, ED | 1 |
| Fletcher, PJ; Higgins, GA; Noble, K; Rizos, Z | 1 |
| Harland, AA; Maglathlin, R; McCorvy, JD; Nichols, DE | 1 |
| Bonhaus, DW; McFarland, K; Price, DL | 2 |
| Hammond, B; Hussain, I; Kew, JN; Stean, TO; Upton, N; Virley, DJ; Waters, KA | 1 |
| Fletcher, PJ; Higgins, GA; Soko, AD | 1 |
| Andersen, ML; Howell, LL; Murnane, KS; Rice, KC | 1 |
| Booth, RG; Canal, CE; Felsing, D; Kondabolu, K; Morgan, D; Robertson, KL; Rowland, NE; Sakhuja, R | 1 |
| Rippberger, H; Schwarting, RK; van Gaalen, MM; Wöhr, M | 1 |
| Bernard, P; Bizot, JC; David, S; Puech, A; Tassin, JP; Trovero, F | 1 |
| Bagnol, D; Duranton, F; Faton, S; Lajoix, AD; Tassin, JP | 1 |
27 other study(ies) available for amphetamine and mdl 100907
| Article | Year |
|---|---|
Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Excitatory Amino Acid Antagonists; Fluorobenzenes; Male; Motor Activity; Phencyclidine; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists | 1995 |
Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist.
Topics: Amphetamine; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Discrimination, Psychological; Fluorobenzenes; Male; Motor Activity; Piperidines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Reward; Self Stimulation; Serotonin Antagonists | 1996 |
Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Fluorobenzenes; Male; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Stereotyped Behavior | 1997 |
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Topics: Amphetamine; Animals; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Haloperidol; Hyperkinesis; Male; Mice; Mice, Inbred Strains; Motor Activity; N-Methylaspartate; Piperazines; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists | 1999 |
5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB.
Topics: Aminopyridines; Amphetamine; Animals; Benzazepines; Cocaine; Dizocilpine Maleate; Dopamine Agonists; Drug Interactions; Female; Fluorobenzenes; Indoles; Mice; Motor Activity; Piperidines; Ritanserin; Serotonin Antagonists | 1999 |
5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Fluorobenzenes; Indophenol; Male; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2003 |
Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.
Topics: Aging; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Clozapine; Conditioning, Classical; Disease Models, Animal; Drinking Behavior; Fluorobenzenes; Male; Models, Neurological; Movement; Neural Inhibition; Piperidines; Rats; Rats, Wistar; Schizophrenia; Time Factors | 2003 |
Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aging; Amphetamine; Analysis of Variance; Animals; Association Learning; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Dose-Response Relationship, Drug; Drug Interactions; Fluorobenzenes; Inhibition, Psychological; Male; Phencyclidine; Phenols; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists; Stereotyped Behavior | 2003 |
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Behavior, Animal; Cues; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Haloperidol; Indans; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Piperidines; Psychotic Disorders; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2005 |
The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.
Topics: Action Potentials; Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; In Vitro Techniques; Male; Mesencephalon; Neural Inhibition; Neurons; Olanzapine; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin 5-HT2 Receptor Antagonists; Sulpiride | 2005 |
Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Amphetamines; Animals; Conditioning, Operant; Drug Interactions; Female; Fluorobenzenes; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Perception | 2006 |
Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
Topics: Amphetamine; Animals; Binding, Competitive; Carbon Radioisotopes; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Indoles; Ketanserin; Male; Positron-Emission Tomography; Protein Binding; Pyridines; Raclopride; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2008 |
Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
Topics: Aminopyridines; Amphetamine; Animals; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nicotine; Nicotinic Agonists; Pyrazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2009 |
Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.
Topics: Amino Acids; Amphetamine; Animals; Antipsychotic Agents; Dizocilpine Maleate; Dopamine; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Agonists; Fluorobenzenes; Male; Motor Activity; Norepinephrine; Nucleus Accumbens; Piperidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Metabotropic Glutamate; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2009 |
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Brain; Dihydro-beta-Erythroidine; Electrodes, Implanted; Fluorobenzenes; Ganglionic Stimulants; Idazoxan; Male; Nicotine; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Serotonin Antagonists; Substance Withdrawal Syndrome | 2010 |
PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.
Topics: Acoustic Stimulation; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Female; Histamine H1 Antagonists; Inhibition, Psychological; Ketanserin; Physical Stimulation; Pyrilamine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists | 2010 |
Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Ethylamines; Excitatory Amino Acid Antagonists; Fluorobenzenes; Impulsive Behavior; Indoles; Male; Piperidines; Psychomotor Performance; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, N-Methyl-D-Aspartate; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2011 |
A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference.
Topics: Aminopyridines; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Dose-Response Relationship, Drug; Indoles; Male; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2011 |
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dyskinesias; Fenfluramine; Fluorobenzenes; Hyperkinesis; Male; Motor Activity; Oxidopamine; Parkinson Disease; Piperidines; Psychotic Disorders; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Serotonin Receptor Agonists; Substantia Nigra; Tyrosine 3-Monooxygenase; Urea | 2011 |
Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition.
Topics: Amphetamine; Animals; Animals, Outbred Strains; Cognition; Disease Models, Animal; Fluorobenzenes; Locomotion; Male; Phencyclidine; Phenols; Piperidines; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Recognition, Psychology; Serotonin Antagonists; Sulfonamides | 2012 |
Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease.
Topics: Alzheimer Disease; Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Drug Inverse Agonism; Male; Mice; Piperidines; Psychotic Disorders; Serotonin 5-HT2 Receptor Antagonists; Urea | 2012 |
Impulsive action in the 5-choice serial reaction time test in 5-HT₂c receptor null mutant mice.
Topics: Aminopyridines; Amphetamine; Animals; Choice Behavior; Cocaine; Dose-Response Relationship, Drug; Ethylamines; Food Deprivation; Impulsive Behavior; Indoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Reaction Time; Receptor, Serotonin, 5-HT2C; Reinforcement Schedule; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2013 |
Selective serotonin 2A receptor antagonism attenuates the effects of amphetamine on arousal and dopamine overflow in non-human primates.
Topics: Amphetamine; Animals; Arousal; Caudate Nucleus; Central Nervous System Stimulants; Circadian Rhythm; Dopamine; Dopamine Uptake Inhibitors; Female; Fluorobenzenes; Macaca mulatta; Microdialysis; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine; Serotonin 5-HT2 Receptor Antagonists; Sleep; Telemetry; Wakefulness | 2013 |
A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
Topics: 2-Naphthylamine; Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Feeding Behavior; HEK293 Cells; Humans; Hyperkinesis; Male; Mice, Inbred C57BL; Motor Activity; Psychotic Disorders; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Stereoisomerism; Time Factors | 2014 |
Critical involvement of 5-HT2C receptor function in amphetamine-induced 50-kHz ultrasonic vocalizations in rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Emotions; Male; Piperazines; Pyrazines; Rats; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Ultrasonic Waves; Vocalization, Animal | 2015 |
The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence.
Topics: Adrenergic alpha-1 Receptor Antagonists; Alcoholism; Amphetamine; Animals; Behavior, Animal; Cyproheptadine; Ethanol; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Piperidines; Prazosin; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists | 2016 |
5-HT
Topics: Aminopyridines; Amphetamine; Animals; Arcuate Nucleus of Hypothalamus; Central Nervous System Stimulants; Eating; Feeding Behavior; Food Deprivation; Indoles; Male; Motivation; Motor Activity; Piperazines; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Reward; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Ventral Tegmental Area | 2018 |